CRISPR Therapeutics AG (CRSP)
40.72
+0.34
(+0.83%)
USD |
NASDAQ |
Dec 20, 16:00
40.87
+0.15
(+0.37%)
After-Hours: 20:00
CRISPR Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 37.71% |
| Lonza Group Ltd | -- |
| AC Immune SA | 21.59% |
| Addex Therapeutics Ltd | -2.84K% |
| NLS Pharmaceutics Ltd | -- |